Recent Finacing
Recent Raise
argenx is a Dutch-Belgian biopharmaceutical company developing human therapeutic antibodies with its SIMPLE Antibody platform, advancing preclinical and clinical programs for autoimmune diseases, inflammation and oncology (e.g., ARGX-110/113/115).
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
